Dolby Laboratories Inc banner

Dolby Laboratories Inc
NYSE:DLB

Watchlist Manager
Dolby Laboratories Inc Logo
Dolby Laboratories Inc
NYSE:DLB
Watchlist
Price: 49.99 USD 1.71% Market Closed
Market Cap: $4.7B

Wall St Price Targets

DLB Price Targets Summary
Dolby Laboratories Inc

Wall Street analysts forecast DLB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DLB is 87.95 USD with a low forecast of 60.6 USD and a high forecast of 119.7 USD.

Lowest Forecast
Price Target
60.6 USD
21% Upside
Average Forecast
Price Target
87.95 USD
76% Upside
Highest Forecast
Price Target
119.7 USD
139% Upside
Dolby Laboratories Inc Competitors:
Price Targets

Revenue
Forecast

3% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
3% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 5%.

Gross Profit
Forecast

3% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
3% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 2 years is 6%.

Operating Income
Forecast

-2% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
-2% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 3 years is 27%.

Pre-Tax Income
Forecast

-1% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
-1% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 2 years is 36%.

Net Income
Forecast

0% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
0% / Year
Past Growth
32% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is 32%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DLB's stock price target?
Price Target
87.95 USD

According to Wall Street analysts, the average 1-year price target for DLB is 87.95 USD with a low forecast of 60.6 USD and a high forecast of 119.7 USD.

What is the Revenue forecast for Dolby Laboratories Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Dolby Laboratories Inc?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 2 years is 6%.

What is the Operating Income forecast for Dolby Laboratories Inc?
Projected CAGR
27%

Over the last 13 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 3 years is 27%.

What is the Pre-Tax Income forecast for Dolby Laboratories Inc?
Projected CAGR
36%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 2 years is 36%.

What is the Net Income forecast for Dolby Laboratories Inc?
Projected CAGR
32%

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is 32%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett